1. Lower lobe origin is related to unfavorable outcomes in patients with stage I–III lung cancer treated with radical chemoradiotherapy
    Fangfang Liu et al, 2021, Tumori Journal CrossRef
  2. Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer
    Branislav Jeremić et al, 2018, Frontiers in Oncology CrossRef
  3. Surgical Treatment for N2 Non-small Cell Lung Cancer
    Seiichiro Sugimoto et al, 2019, Haigan CrossRef
  4. Exposure of the heart in lung cancer radiation therapy: A systematic review of heart doses published during 2013 to 2020
    Maeve Kearney et al, 2022, Radiotherapy and Oncology CrossRef
  5. Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations
    Hyun Woo Lee et al, 2020, Scientific Reports CrossRef
  6. The Feasibility of Median Sternotomy With or Without Thoracotomy for Locally Advanced Non-Small Cell Lung Cancer Treated With Induction Chemoradiotherapy
    Hiroki Sato et al, 2016, The Annals of Thoracic Surgery CrossRef
  7. Role of surgery in N2 NSCLC: pros
    Kazuhiko Shien et al, 2016, Japanese Journal of Clinical Oncology CrossRef
  8. Location of stage I–III non‐small cell lung cancer and survival rate: Systematic review and meta‐analysis
    Hyun Woo Lee et al, 2018, Thoracic Cancer CrossRef
  9. Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC
    Diem Vuong et al, 2021, Scientific Reports CrossRef
  10. Clinical Predictors of Persistent Mediastinal Nodal Disease After Induction Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer
    Mohamed K. Kamel et al, 2017, The Annals of Thoracic Surgery CrossRef
  11. Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis
    Shan xian Guo et al, 2016, Scientific Reports CrossRef
  12. Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer
    Kuniaki Katsui et al, 2021, International Journal of Clinical Oncology CrossRef
  13. Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis
    Myra van Laar et al, 2020, Radiotherapy and Oncology CrossRef